3692.HK · HANSOH PHARMA
Hong Kong · RS rating 34 · As of 2026-10-14
| Price | 30.58 HKD |
|---|---|
| 1-day change | -3.0% |
| RS rating (overall / 1M / 3M / 12M) | 34 / 22 / 44 / 50 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 27 / 10 / 13 |
| Industry group (rank) | Pharma & Biotech (30) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +29.5% |
| Market cap (USD) | $24.4B |